Have a personal or library account? Click to login
Comparison of Carotid Artery Dose in Early-Stage Glottic Cancer Treated with 3D-Conformal, Helical-IMRT and VMAT Cover

Comparison of Carotid Artery Dose in Early-Stage Glottic Cancer Treated with 3D-Conformal, Helical-IMRT and VMAT

Open Access
|Nov 2023

Figures & Tables

Figure 1:

Dose distribution with prescribed isodose curves (50% in dark blue, 80% in light blue, and 95% in orange) for four patients with T1–2 left glottic squamous cell cancer, who underwent radical radiotherapy at a dose of 63–65.25 Gy in 28–29 fractions over 5.6–5.8 weeks. The red volumes represent the clinical target volume (CTV) and the planning target volume (PTV). Axial slices of representative cases were planned using (A) 3D-conformal radiotherapy with opposed lateral fields, (B) 3D-conformal radiotherapy with oblique beams, (C) helical tomotherapy-intensity-modulated radiotherapy, and (D) volumetric modulated arc therapy.
Dose distribution with prescribed isodose curves (50% in dark blue, 80% in light blue, and 95% in orange) for four patients with T1–2 left glottic squamous cell cancer, who underwent radical radiotherapy at a dose of 63–65.25 Gy in 28–29 fractions over 5.6–5.8 weeks. The red volumes represent the clinical target volume (CTV) and the planning target volume (PTV). Axial slices of representative cases were planned using (A) 3D-conformal radiotherapy with opposed lateral fields, (B) 3D-conformal radiotherapy with oblique beams, (C) helical tomotherapy-intensity-modulated radiotherapy, and (D) volumetric modulated arc therapy.

Figure 2:

Verification of differences in mean and maximum doses (Gy) to carotid arteries among treatment techniques using the nonparametric Kruskal–Wallis test.
Verification of differences in mean and maximum doses (Gy) to carotid arteries among treatment techniques using the nonparametric Kruskal–Wallis test.

Summary of the patients’ demographics and disease and treatment characteristics for the three different radiotherapy techniques utilized in this study_

CharacteristicsTreatment techniqueSignificance

3D-CRT (n = 14) (%)HT-IMRT (n = 8) (%)VMAT (n = 6) (%)
Sex p = 0.7
Female1 (7.1)1 (12.5)0 (0.0)
Male13 (92.9)7 (87.5)6 (100.0)
Age at diagnosis p = 0.1
<60 years3 (21.4)1 (12.5)4 (66.7)
≥60 years11 (78.6)7 (87.5)2 (33.3)
Performance status p = 0.1
ECOG 014 (100.0)6 (75.0)6 (100.0)
ECOG 10 (0.0)2 (25.0)0 (0.0)
Prognostic stage groups p = 0.3
Stage 02 (14.3)0 (0.0)0 (0.0)
Stage I11 (78.6)5 (63.5)4 (66.7)
Stage II1 (7.1)3 (37.5)2 (33.3)
Tumor location/target treatment volume p = 0.4
Both vocal cords4 (28.6)3 (37.5)1 (16.7)
Right vocal cord4 (28.6)2 (25.0)0 (0.0)
Left vocal cord6 (42.9)3 (37.5)5 (83.3)
Mean ± SD total radiation dose (Gy)64.9 ± 1.762.4 ± 5.464.4 ± 1.5p = 0.2
Mean ± SD no. of fractions received31.2 ± 2.529.3 ± 4.329.8 ± 2.5p = 0.3
Mean ± SD dose per fraction (Gy)2.1 ± 0.12.2 ± 0.22.2 ± 0.1p = 0.4

Comparison of dosimetric characteristics among the three treatment techniques_

ParameterTreatment techniqueSignificance

3D-CRT (n = 14)HT-IMRT (n = 8)VMAT (n = 6)
Right carotid artery
Mean dose, Gy (range)30.9 (15.8–47.4)27.6 (23.2–34.6)16.6 (13.0–47.4)p = 0.01
Dmax, Gy (range)51.7 (24.6–68.9)49.9 (32.2–62.4)31.9 (26.1–48.2)p = 0.02
Mean volume delineated, ml (range)5.0 (3.6–6.4)3.9 (2.8–5.8)4.2 (2.6–6.5)p = 0.1
Left carotid artery
Mean dose, Gy (range)31.0 (20.1–43.7)28.2 (19.0–43.2)23.4 (15.5–30.1)p = 0.1
Dmax, Gy (range)54.0 (30.4–67.1)49.7 (30.4–66.2)48.4 (31.5–60.9)p = 0.6
Mean volume delineated, ml (range)4.7 (3.1–6.2)4.0 (3.0–5.8)4.0 (2.5–5.6)p = 0.3
DOI: https://doi.org/10.2478/fco-2023-0009 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X
Language: English
Page range: 23 - 30
Submitted on: Jun 19, 2023
Accepted on: Oct 7, 2023
Published on: Nov 13, 2023
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2023 B Pires, D Rothwell, I Guimarães, J Sousa, R Magalhães, T Serra, L Khouri, P Alves, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.